Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 avr. 2026 02h00 HE | Source: Trogenix

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain...
08 avr. 2026 11h03 HE | Source: Trogenix

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain...
04 juin 2015 11h13 HE | Source: Sir Emeka Offor Foundation

Sir Emeka Offor Foundation Cautiously Optimistic as Campaign to END POLIO NOW in Nigeria Nears Milestone

SAO PAULO, Brazil, June 4, 2015 (GLOBE NEWSWIRE) -- With an important milestone in the effort to END POLIO NOW throughout Nigeria just weeks away, the Sir Emeka Offor Foundation today urged political,...